Viewbix (Nasdaq:VBIX) Acquires Quantum X Labs, Expands Quantum Technology Portfolio

3/4/2026, 6:39:18 AM

Tel Aviv, Israel — March 4, 2026 — Leads & Copy — Viewbix Inc. (Nasdaq: VBIX) has completed the acquisition of Quantum X Labs Ltd., a quantum technology hub focused on quantum algorithms, navigation, and atomic clocks.

Viewbix, an advanced technologies company, announced the completion of the acquisition, which was made pursuant to the definitive share purchase agreement dated December 15, 2025. The acquisition includes Quantum’s proprietary intellectual property portfolio, featuring a patent for AI-Quantum Error Correction.

Quantum operates portfolio companies developing solutions in quantum-based navigation, including GPS alternatives, next-generation atomic clocks for precision timing, quantum algorithms for sectors like transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies.

In connection with the closing, Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the Agreement Date. This includes 800,000 shares of common stock issued in a related private placement. There is also potential additional consideration of up to 12,702,847 shares of the company’s common stock or pre-funded warrants upon achievement of specified post-closing milestones.

Viewbix also closed a private placement of approximately $1.4 million shares of the company’s common stock and warrants to purchase common stock. The company issued an aggregate of 800,000 shares of common stock at a price of $1.75 per share. Additionally, the company issued an aggregate of 640,000 common warrants, each exercisable for one share of common stock, at an exercise price of $2.625 per share to the investors in the private placement for no additional consideration.

The common warrants are exercisable upon issuance and have a term of 5 years from the issuance date. Aggregate gross proceeds to the company were approximately $1.4 million, before deducting offering expenses payable by the company. The company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.

The securities described above were issued and/or sold in private placement transactions not involving a public offering and exempt from the registration requirements of the Securities Act of 1933, as amended. The securities were offered only to accredited investors.

Viewbix operates in the field of digital advertising through its subsidiaries Gix Media Ltd. and Metagramm Software Ltd. Gix Media develops technological software solutions for automation, optimization, and monetization of internet campaigns. Metagramm develops grammatical error correction software, offering tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

Source: Viewbix Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.